Trial Profile
PeriOcular and INTravitreal Corticosteroids for Uveitic Macular Edema Trial
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 08 Nov 2018
Price :
$35
*
At a glance
- Drugs Dexamethasone (Primary) ; Triamcinolone (Primary) ; Triamcinolone (Primary)
- Indications Retinal oedema; Uveitis
- Focus Therapeutic Use
- Acronyms POINT
- 30 May 2018 Status changed from suspended to completed.
- 26 Jul 2017 Status changed from recruiting to suspended due to non safety reasons.
- 16 Jun 2015 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.